Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Cytokinetics, Incorporated (CYTK) News - StockMarketCap

Stocks›Cytokinetics, Incorporated☆

● At closeAs of Jul 2, 2026

Cytokinetics, Incorporated

CYTK✓

HealthcareBiotechnologyNASDAQ

$86.49+1.44%

$10.76BMarket cap

-12.51xP/E ratio

2.00MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$86.49

$1.23 (+1.44%) · 24h

Key metrics

Market cap$10.76B+15.62%

Enterprise value$11.79B

Volume (24h)2.00M

P/E ratio (TTM)-12.51x

P/S ratio (TTM)100.48x

Dividend yield0.00%

Shares outstanding124.43M

Trading range

Previous close$85.26

Day range$84.63 - $87.42

52-week range$32.66 - $88.31

Cytokinetics, Incorporated (CYTK) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news